Mixed options sentiment in Bristol Myers Squibb (BMY), with shares up 36c, or 0.72%, near $49.41. Options volume roughly in ...
DelveInsight's Mycosis Fungoides Market Insights report includes a comprehensive understanding of current treatment practices, mycosis fungoides emerging drugs, market share of individual therapies, ...
The "Gene Therapy Collaboration and Licensing Deals 2016-2025" has been added to ResearchAndMarkets.com's offering.This report contains a comprehensive listing of 787 gene therapy deals announced ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback